Summary

Chronic low back pain represents one of the most pervasive musculoskeletal disorders worldwide, imposing substantial financial strain on individuals, healthcare systems and economies. Direct costs encompass expenditures on medical consultations, imaging, interventions and rehabilitation, while indirect costs arise from lost work productivity, absenteeism and early retirement. In high-income nations, annual per-patient direct costs can exceed USD 9,000, with total national burdens measured in tens of billions. Low- and middle-income countries face a rising share of this burden, often without commensurate resources to manage it. The economic impact is magnified by demographic ageing, sedentary occupations and incomplete adherence to clinical guidelines, leading to recurrent healthcare utilisation and long-term disability. Prevention strategies, early intervention and integrated care pathways have been shown to curb expenses by reducing episode duration and mitigating productivity losses. Overall, chronic low back pain represents a multifaceted fiscal challenge requiring coordinated efforts across public health, occupational policy and clinical practice to limit its societal toll.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Economic Burden of Chronic Low Back Pain publication trend

The graph below shows the total number of articles in economic burden of chronic low back pain across all publications each year (not limited to Nature Index journals).

Technical terms

Direct costs: Healthcare expenses such as consultations, imaging, treatments and rehabilitation associated with chronic low back pain.

Indirect costs: Economic losses resulting from reduced work productivity, sick leave and early retirement due to chronic low back pain.

Cost-of-illness analysis: Methodology estimating the financial impact of a disease on society by quantifying both direct and indirect costs.

Societal perspective: Analytical viewpoint that incorporates all costs and consequences of a health condition across the broader community, rather than solely on healthcare payers.

References

  1. Global and regional estimates of clinical and economic burden of low back pain in high-income countries: a systematic review and meta-analysis. Frontiers in Public Health (2023).
  2. The economic burden of low back pain in KwaZulu-Natal, South Africa: A prevalence-based cost-of-illness analysis from the healthcare provider’s perspective. PLOS ONE (2022).
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.